Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04655404
Title A Pilot Study of Larotectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion (CONNECT1903)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nationwide Children's Hospital
Indications

high grade glioma

diffuse midline glioma, H3 K27M-mutant

anaplastic astrocytoma

glioblastoma

brain stem glioma

Therapies

Larotrectinib

Age Groups: adult | child
Covered Countries USA | DEU | CAN


No variant requirements are available.